HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > Morgan & Morgan

Print e mail rss del Y! myWeb Tweet
 

Gadolinium MRI Contrast Agent Information Center Released by Morgan & Morgan

The lawyers at Morgan & Morgan (ForThePeople.com) are currently investigating cases of Nephrogenic Systemic Fibrosis (NSF) in patients who were injected with a gadolinium contrast agent for an MRI or MRA.

(EMAILWIRE.COM, January 05, 2009 ) Orlando, FL - The lawyers at Morgan & Morgan (ForThePeople.com) are currently investigating cases of Nephrogenic Systemic Fibrosis (NSF) in patients who were injected with a gadolinium contrast agent for an MRI or MRA. A new gadolinium information center has been created on their website to help educate consumers about the risks posed by gadolinium contrast agents for individuals with kidney problems.

Gadolinium is a chemical element that is often used in MRI (Magnetic Resonance Imaging), MRA (Magnetic Resonance Angiogram), X-Ray, and other imaging technology as a contrast agent to enhance the quality of the image. In 2007, the Food and Drug Administration (FDA) issued its strongest warning (the Black Box Warning) for MRI/MRA contrast agents that contain Gadolinium because it has been linked to a potentially fatal disease in patients with existing kidney conditions.

Nephrogenic Systemic Fibrosis (NSF), also called Nephrogenic Fibrosing Dermopathy (NFD), is a potentially life threatening disease for which there is no consistently effective treatment. NSF is a systemic condition in which excessive connective tissue forms in the skin and internal organs. Symptoms of NSF/NFD include swelling, thickening and hardening skin in the extremities and occasionally in the torso/trunk area, as well as muscle weakness, hardening of internal organs, and reddened or darkened skin patches. Nearly all cases of Nephrogenic Systemic Fibrosis can be directly attributed to gadolinium injections in patients with advanced or end-stage kidney disease.

Morgan & Morgan’s gadolinium information center features detailed information about gadolinium and NSF. Frequently asked questions about gadolinium, gadolinium side effects, information about gadolinium brand names and FDA warnings, MRI injection lawsuits, and more are available on the site. If you or a loved one has been diagnosed with NSF after being injected with a gadolinium based contrast agent, it is important to be aware of your legal rights. Visit http://www.forthepeople.com/Gadolinium_Warning.htm to learn more. Morgan & Morgan’s gadolinium lawyers offer a free legal case evaluation for NSF victims throughout the United States.

About Morgan & Morgan

Morgan & Morgan is one of the largest Personal Injury law firms in the country with offices nationwide. The firm handles cases against drug and medical device manufacturers, as well as food poisoning and consumer fraud cases. Visit http://www.forthepeople.com for a free case evaluation and information about your legal rights.

Contact Information:
Morgan & Morgan
Liz Ryan
Tel: 908-222-8848
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Press Release Keywords:

gadolinium contrast agent, morgan & morgan, morgan and morgan, for the people, attorney john morgan, nsf mri, gadolinium mri, gadolinium contrast agent, nephrogenic fibrosing dermopathy, mri contrast a

Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012